Detection and isolation of circulating tumor cells in urologic cancers: a review.

The American Cancer Society has estimated that in 2003, there will be approximately 239,600 new cases of urologic cancer diagnosed and 54,600 urologic cancer-related deaths in the United States. To date, the majority of research and therapy design have focused on the microenvironment of the primary tumor site, as well as the microenvironment of the metastatic or secondary (target) tumor site. Little attention has been placed on the interactions of the circulating tumor cells and the microenvironment of the circulation (i.e., the third microenvironment). The purpose of this review is to present the methods for the detection and isolation of circulating tumor cells and to discuss the importance of circulating tumor cells in the biology and treatment of urologic cancers.

[1]  O. Ogawa,et al.  Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  M. Wirth,et al.  Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol. , 2002, International journal of oncology.

[3]  A. Weiss,et al.  Detection and characterization of carcinoma cells in the blood. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Stöckle,et al.  Cytokeratin–20 Reverse–Transcriptase Polymerase Chain Reaction as a New Tool for the Detection of Circulating Tumor Cells in Peripheral Blood and Bone Marrow of Bladder Cancer Patients , 2001, European Urology.

[5]  G. Doyle,et al.  Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status. , 2001, Urology.

[6]  I. Fidler.  The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. , 1973, European journal of cancer.

[7]  Ablin Rj.  Re: Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. , 1993 .

[8]  W. Gerald,et al.  Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Jan Greve,et al.  Magnetic field design for selecting and aligning immunomagnetic labeled cells. , 2002, Cytometry.

[10]  R. Riesenberg,et al.  Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro. , 2000, The Journal of urology.

[11]  S. Stevanović,et al.  Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients , 2002, International journal of cancer.

[12]  P. Kantoff,et al.  Detection of circulating tumor cells in men with localized prostate cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  U. Stenman,et al.  Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. , 1995, Clinical chemistry.

[14]  I. Fidler,et al.  Metastatic potential of human neoplasms. , 2002, In vivo.

[15]  J. Rosai,et al.  Molecular detection of micrometastases and circulating tumor cells in solid tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[17]  L. Chow,et al.  Immunomagnetic Tumor Cell Enrichment Is Promising in Detecting Circulating Breast Cancer Cells , 2003, Oncology.

[18]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[19]  B. Stein,et al.  Application of immunomagnetic beads in combination with RT‐PCR for the detection of circulating prostate cancer cells , 1997, Journal of clinical laboratory analysis.

[20]  D. Neal,et al.  Adhesion of lymphocytes to bladder cancer cells: the role of the αEβ7 integrin , 2002, Cancer Immunology, Immunotherapy.

[21]  L. Chung.  Prostate carcinoma bone‐stroma interaction and its biologic and therapeutic implications , 2003, Cancer.

[22]  L. Frati,et al.  Epidermal growth factor receptor mRNA expression in peripheral blood of bladder cancer patients: a potential marker to detect treatment failure. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  A. Raz,et al.  Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. , 1999, Cancer research.

[24]  F. Hamdy,et al.  The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer , 1999, British Journal of Cancer.

[25]  F. Hamdy,et al.  Haematogenous dissemination of prostate epithelial cells during surgery , 1996, The Lancet.

[26]  Bingham Ja.  Letter: Lower oesophageal sphincter. , 1974 .

[27]  Marije Deutekom,et al.  Tumor markers in the diagnosis of primary bladder cancer. A systematic review. , 2003, The Journal of urology.

[28]  R. Tubbs,et al.  Circulating cancer cells in renal-cell carcinoma. , 1990, Progress in clinical and biological research.

[29]  C. Cordon-Cardo,et al.  Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction. , 1999, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[30]  T. Isono,et al.  Detection of circulating testicular cancer cells in peripheral blood. , 1999, Cancer letters.

[31]  J. Segall,et al.  A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. , 2000, Cancer research.

[32]  S. Bustin,et al.  Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients. , 2000, International journal of surgical investigation.

[33]  J. Soria,et al.  The molecular detection of circulating tumor cells in bladder cancer using telomerase activity. , 2002, The Journal of urology.

[34]  S. Nakamura,et al.  Detection of circulating cancer cells with von hippel-lindau gene mutation in peripheral blood of patients with renal cell carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  N. Bander,et al.  Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasion. , 2000, Cancer detection and prevention.

[36]  B. Tombal,et al.  Prognostic value of circulating prostate cells in patients with a rising PSA after radical prostatectomy , 2003, The Prostate.

[37]  D. Tindall,et al.  Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages. , 1997, Urology.

[38]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[39]  M. Banerjee,et al.  Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  A W Partin,et al.  Detection of intact prostate cancer cells in the blood of men with prostate cancer. , 1997, Urology.

[41]  W. Ellis,et al.  The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer. , 1998, The Journal of urology.

[42]  R. Vessella,et al.  Mechanisms, Hypotheses and Questions Regarding Prostate Cancer Micrometastases to Bone , 1998, Cancer and Metastasis Reviews.

[43]  W. Ellis,et al.  Detection and isolation of prostate cancer cells from peripheral blood and bone marrow. , 2003, Urology.

[44]  B. Lacour,et al.  Molecular Detection of Circulating Prostate Cells in Cancer Ii: Comparison of Prostate Epithelial Cells Iso- Lation Procedures , 2022 .

[45]  H Heynemann,et al.  Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation , 2001, International journal of cancer.

[46]  S Miltenyi,et al.  Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. , 1998, Experimental hematology.

[47]  M. Cohen,et al.  5E10: a prostate-specific surface-reactive monoclonal antibody. , 1998, Cancer letters.

[48]  P. Gullino,et al.  Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. , 1975, Cancer research.

[49]  V. Bilim,et al.  Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy , 2001, British Journal of Cancer.

[50]  E. Mayhew,et al.  Selective therapy of metastasis. I. Quantitation of tumorigenic circulating and covert cancer cells disseminated from metastatic and nonmetastatic tumors. , 1984, Cancer drug delivery.

[51]  N. Brousse,et al.  Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence. , 2000, The Journal of urology.

[52]  D. Jacqmin,et al.  Detection of Prostate-Specific Antigen- or Prostate-Specific Membrane Antigen-Positive Circulating Cells in Prostatic Cancer Patients: Clinical Implications , 1999, European Urology.

[53]  P. Kantoff,et al.  Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: a nested study within CALGB 9583. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  M. Rubin,et al.  The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase–polymerase chain reaction assay for MN/CA9 , 1999, Cancer.

[55]  A W Partin,et al.  Identification and characterization of circulating prostate carcinoma cells , 2000, Cancer.

[56]  K. Pienta,et al.  Stromal factors involved in prostate carcinoma metastasis to bone , 2003, Cancer.

[57]  T. Sun,et al.  Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder. , 1999, The Journal of urology.

[58]  C. Bucana,et al.  The seed and soil hypothesis: vascularisation and brain metastases. , 2002, The Lancet. Oncology.

[59]  V. Bilim,et al.  Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.